Healthcare Professionals
About AGGRASTAT
®
Indications and Usage
Dosing and Administration
Efficacy
Safety and Tolerability Profile
ACS Guidelines
Key AGGRASTAT Studies
PRISM
PRISM-PLUS
TACTICS
A to Z Trial
ACUTE II
TIMI Criteria
High-Risk Patients
ST-Segment Changes
Renal Insufficiency
Diabetes
Elevated Troponin-I
Resources
Prescribing Information
Slide Sets
Useful Links
Email Me Updates
Request More Information
Please contact MSD at:
Merck, Sharp & Dohme
P.O.Box 17098, Riyadh 11484
Saudi Arabia
Telephone: 00966 1 4056320
Fax: 00 966 1 4067734
Full Name
*
Full Work Address
*
Please enter your full work address here...
Telephone
*
E-mail:
*
*
Indicates a required field
AGGRASTAT is a registered trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA
